Crossmark

Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function

Crossref DOI link: https://doi.org/10.1186/s13550-018-0455-8

Published Online: 2018-11-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Plavén-Sigray, Pontus https://orcid.org/0000-0001-5342-5641
Matheson, Granville James

Cselényi, Zsolt

Jucaite, Aurelija

Farde, Lars

Cervenka, Simon
License Information

Text and Data Mining valid from 2018-11-29
More Information

Article History

Received: 4 July 2018

Accepted: 2 November 2018

First Online: 29 November 2018

Ethics approval and consent to participate

: The study was approved by the Stockholm Regional Ethical Board and carried out in accordance with the Helsinki declaration. Informed consent was obtained from all individual participants included in the study.

: Not applicable.

: The data collection in the original study [] was funded by AstraZeneca. LF, ZC, and AJ are employees at AstraZeneca. AstraZeneca had no role in the idea behind or design of the re-analyses of data carried out in this article. The remaining authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.